Medications

Antimalarial medication details and usage instructions

Product Type Filter

Artesunate for Injection (Artesun®)

Injection Artesun® Triple Pack
Registered Trademark: Artesun®

Product Specifications

Specifications 30mg, 60mg, 120mg
Packaging Triple pack: Lyophilized powder + 0.5ml Sodium Bicarbonate (50mg/ml) + 2.5ml Sodium Chloride (9mg/ml)
Pack Size 30mg: (1+1+1) vials/box; 5×20 boxes/carton
Applicable Regions Sudan, Tanzania, Zambia, Malawi, etc.

Indications

  • Severe malaria caused by Plasmodium falciparum
  • Cerebral malaria
  • Severe cases unresponsive to oral antimalarial drugs

Dosage

Dosage Calculation Formula:

• Weight >20kg: Dose(mg) = Weight(kg) × 2.4

• Weight ≤20kg: Dose(mg) = Weight(kg) × 3

• Concentration after reconstitution: 20mg/ml

Dosage Guide

Patient Weight 30mg 60mg 120mg
≤25kg 1 box 1 vial -
26-50kg 2 boxes 2 vials 1 vial
51-75kg 3 boxes 3 vials 1½ vials
76-100kg 4 boxes 4 vials 2 vials

Important Information

Registration Numbers:

Sudan: INJ/05/5444; Tanzania: TZ12H036; Zambia: 043/008; Malawi: PMPB/PL397/6; Nigeria: A4-9524

Storage: Below 30°C, protected from light; reconstituted solution below 30°C, use within 1 hour

Manufacturer: Guilin Pharma Co., Ltd.

Artesunate for Injection (Argesun®)

Injection Argesun® Dual Pack
Registered Trademark: Argesun®

Product Specifications

Specifications 30mg, 60mg, 120mg, 180mg
Packaging Dual pack: Lyophilized powder + 6.0ml Sodium Bicarbonate & Arginine (8.4mg/ml + 20mg/ml)
Pack Size 120mg: (1+1) vials/box; 5×48 boxes/carton
Applicable Regions Malawi, Tanzania, Zambia, Nigeria, etc.

Indications

  • Severe malaria caused by Plasmodium falciparum
  • Severe pediatric malaria (30mg spec designed for children)
  • Chloroquine-resistant malaria infections

Dosage

Dosage Calculation Formula:

• Weight >20kg: Dose(mg) = Weight(kg) × 2.4

• Weight ≤20kg: Dose(mg) = Weight(kg) × 3

• Concentration after reconstitution: 15mg/ml (30mg) / 20mg/ml (60/120mg)

Dosage Guide

Patient Weight 30mg 60mg 120mg
≤25kg 2 vials 1 vial -
26-50kg 4 vials 2 vials 1 vial
51-75kg 6 vials 3 vials 1½ vials
76-100kg 8 vials 4 vials 2 vials

Important Information

Registration Numbers:

Malawi: PMPB/PL518/11; Tanzania: TAN20HM0421; Zambia: ZAMRA-HM-22-51; Nigeria: A4-100909

Storage: Original packaging below 30°C, protected from light; do not refrigerate or freeze; use within 1 hour after reconstitution

Manufacturer: Guilin Pharma Co., Ltd.

Dihydroartemisinin Piperaquine Dispersible Tablets (D-ARTEPP® Dispersible)

Dispersible Tablets For children and patients with difficulty swallowing

Product Specifications

Specifications 20mg/160mg, 30mg/240mg, 40mg/320mg
Pack Size 20mg/160mg: 3 tabs/blister × 2 blisters/box; 10 boxes/pack × 80 packs/carton
Administration Disperse in water before taking, oral route (Voie orale)
Target Population Children ≥6 months and weight ≥5kg
Excipient Contains Sucralose

Medication Guide

  • Treatment course: 3 consecutive days, once daily
  • Method: Disperse each tablet in at least 10ml water, single dose not exceeding 50ml water
  • Timing: 3 hours before or after meals, on an empty stomach
  • Storage: In sealed container, protected from light and moisture, temperature not exceeding 25°C

Dosage Calculation Table

Weight Range 20mg/160mg 30mg/240mg 40mg/320mg Course
5kg - <8kg 1 tab/day - - Once daily
for 3 days
8kg - <11kg - 1 tab/day -
11kg - <17kg 2 tabs/day - 1 tab/day
17kg - <25kg 3 tabs/day 2 tabs/day -
25kg - <36kg 4 tabs/day - 2 tabs/day
36kg - <60kg 6 tabs/day 4 tabs/day 3 tabs/day
60kg - <80kg 8 tabs/day - 4 tabs/day
≥80kg 10 tabs/day - 5 tabs/day

Registration Numbers:

Tanzania: TZ16H0343; Malawi: PMPB/PL518/5; Zambia: 043/018; Sudan: 13191

Manufacturer: Guilin Pharma Co., Ltd.

Dihydroartemisinin Piperaquine Tablets (D-ARTEPP® Tablets)

Tablets For adults and children ≥17kg

Product Specifications

Specifications 40mg/320mg, 60mg/480mg, 80mg/640mg
Pack Size 80mg/640mg: 6 tabs/blister/box; 10 boxes/pack × 30 packs/carton
Administration Swallow whole, oral route (Voie orale)
Excipient No known effect excipient

Dosage Calculation Table

Weight Range 40mg/320mg 60mg/480mg 80mg/640mg
17kg - <25kg 1.5 tabs/day 1 tab/day -
25kg - <36kg 2 tabs/day - 1 tab/day
36kg - <60kg 3 tabs/day 2 tabs/day 1.5 tabs/day
60kg - <80kg 4 tabs/day - 2 tabs/day
≥80kg 5 tabs/day - 2.5 tabs/day

Course: Once daily for 3 consecutive days

Important Information

Registration Numbers:

Malawi: PMPB/PL518/8; Tanzania: TZ17H0252; Zambia: 043/016; Sudan: 12526

Contraindications:

Quinidine, Amiodarone, Fluoroquinolone antibiotics, some antidepressants, antipsychotics, etc.

Precautions:

  • • Storage: In sealed container, protected from light and moisture, temperature not exceeding 25°C
  • • Contraindicated in patients with cardiac history or electrolyte imbalance
  • • Do not exceed 2 courses within 1 year; minimum 2-month interval between courses
  • • Manufacturer: Guilin Pharma Co., Ltd.

General Medication Guidance

Storage Conditions

  • • Injections: Below 30°C, do not exceed 30°C, do not refrigerate or freeze
  • • Tablets: Below 25°C, sealed, protected from light and moisture
  • • Keep in moisture-proof sealed container
  • • Keep out of reach of children

Expiry Management

  • • Check expiry date before use
  • • Do not use expired medication
  • • Injections: Use within 1 hour after reconstitution
  • • Dispose of unused medication according to local regulations

Emergency Handling

  • • Allergic reaction: Stop medication immediately and seek medical attention
  • • Vomiting: Re-dose at appropriate intervals
  • • Overdose: Contact medical professional immediately
  • • Adverse reactions: Record symptoms and report promptly